Self-assembled Peptide-derived Proteolysis-targeting Chimera (PROTAC) Nanoparticles for Tumor-targeted and Durable PD-L1 Degradation in Cancer Immunotherapy
Angew. Chem.-Int. Edit., Nov 21 2024, | https://doi.org/10.1002/anie.202414146
In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity
J. Nanobiotechnol., 2023 Mar 9;21(1):82 | https://doi.org/10.1186/s12951-023-01824-3